Page 19 - ANTIFUNGAL SUSCEPTIBILITY OF CLINICAL YEAST ISOLATES 2018-2020
P. 19
The antifungal susceptibility patterns and percentages are shown in Table
4.3. and Figure 4.1.
Table 4.3: Antifungal susceptibility patterns and percentages of C. glabrata
complex.
Antifungal Percentage (n) of isolates
agents
S I SDD R WT NWT
Anidulafungin 96.9% (156) 1.2% (2) 1.9% (3)
Caspofungin 54.9% (90) 34.1% (56) 11.0% (18)
Micafungin 97.7% (40) 0.0% (0) 2.3% (1)
Voriconazole 75.4% (126) 24.6% (41)
Fluconazole 94.6% (141) 5.4% (8)
Posaconazole 36.4% (4) 63.6% (7)
Itraconazole 87.8% (129) 12.2% (18)
Amphotericin 99.4% (162) 0.6% (1)
B
19 |
